Welcome to our dedicated page for NATIONAL HEALTHCARE SEC filings (Ticker: NHC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
National HealthCare Corporation filings document operating results, dividend actions, governance matters and capital-structure disclosures for a publicly traded senior health care company. The company’s 8-K reports include earnings releases, quarterly common dividend announcements, director appointments and other material-event disclosures, with NHC common stock registered on the NYSE American.
Proxy materials cover annual meeting matters, shareholder voting, board structure and committee governance. The filing record also describes NHC’s skilled nursing, senior living, behavioral health, home care, hospice, pharmacy, rehabilitation and third-party management activities, along with financial reporting topics such as GAAP and non-GAAP results, marketable equity securities and acquired White Oak operations.
National HealthCare Corporation declared a higher quarterly cash dividend, signaling a modest boost in shareholder returns. The company will pay a quarterly dividend of $0.67 per common share to shareholders of record on June 30, 2026, with payment on July 31, 2026. This dividend represents a 4.7% increase over the prior quarter’s regular common dividend, indicating steady, incremental growth in its cash distributions.
As of May 1, 2026, NHC affiliates operate 80 skilled nursing facilities with 10,323 beds, along with assisted and independent living communities, behavioral health hospitals, homecare and hospice agencies, and related services such as pharmacy and rehabilitation. The company also highlights typical healthcare industry risks and includes standard forward-looking statement cautions.
NATIONAL HEALTHCARE CORP director Richard F. LaRoche Jr. exercised stock options to acquire 7,500 shares of common stock on 2026-05-05 at an exercise price of $71.64 per share. After this derivative exercise, he directly holds 213,260 common shares.
He also retains four additional option grants under the company’s equity plans, each for 7,500 underlying shares, with exercise prices between $55.75 and $96.03 and expiration dates from 2027-05-04 through 2030-05-07, indicating a continuing equity stake through unexercised options.
National Healthcare Corp. director Emil E. Hassan reported an option exercise that increased his direct common stock holdings. On April 30, 2026, he exercised an option for 7,500 shares of common stock at an exercise price of $71.64 per share, moving those shares into direct ownership so that he now holds 73,095 shares of common stock directly.
The exercised option was the 2021 grant, which covered 7,500 underlying shares at $71.64; that option position is now fully used with zero options remaining from that grant. He also continues to hold four other option grants under the company’s equity plans, each covering 7,500 underlying shares with exercise prices of $94.66, $96.03, $55.75, and $69.19, expiring between 2027 and 2030. A footnote states these stock options were granted under the 2020 Omnibus Equity Incentive Plan and that the grant and exercise are exempt from Section 16(b) under Rule 16b-3(d).
National HealthCare Corp reports beneficial ownership by Vanguard Portfolio Management. Vanguard Portfolio Management beneficially owned 794,305 shares of Common Stock, equal to 5.11% as of 03/31/2026.
The filing states Vanguard has sole power to dispose of 794,305 shares and sole voting power for 4,884 shares. The disclosure describes holdings across Vanguard affiliates and client accounts and is signed by a Vanguard officer.
NATIONAL HEALTHCARE CORP senior vice president of patient services Vicki L. Dodson exercised stock options and adjusted her equity holdings. On the reported date, she exercised options to acquire 4,000 shares of common stock at $94.10 per share.
The company withheld 2,853 shares at a value of $173.63 per share to cover the option exercise price and related tax obligations, a non‑market, tax-withholding disposition. Following these transactions, she directly owns about 18,412.5455 shares of common stock and retains stock options over 14,000 shares at $157.13 and 9,000 shares at $90.62, expiring in 2031 and 2030, respectively.
National HealthCare Corporation agreed to buy the real estate of 32 skilled nursing facilities and three independent living facilities it currently leases from National Health Investors for $560 million. The assets span seven states and will shift NHC from tenant to owner for most locations.
NHC will fund the purchase partly through a new credit facility and must place a $5 million initial deposit, followed by an additional $15 million deposit if it proceeds after a due‑diligence review period ending by May 29, 2026. NHI will post a $20 million liquidated damages deposit that NHC can claim in certain seller default scenarios.
The transaction is expected to close in the third quarter of 2026, subject to customary conditions, including Hart‑Scott‑Rodino clearance. The existing master lease will be terminated for most facilities at closing, but four Florida skilled nursing facilities will remain leased to a third‑party operator under an assigned master lease.
National Healthcare Corp Senior VP & CIO Ben Anderson Flatt Sr filed an amended insider report to correct a prior disclosure about shares withheld for taxes and exercise costs. The company withheld 2,109 shares of common stock at $176.81 per share to cover these obligations.
After this tax-withholding disposition, he directly holds 21,175.0547 shares of common stock. He also retains option awards covering 31,000 underlying shares at exercise prices of $94.10, $90.62, and $157.13, with expirations between 2029 and 2031.
National Healthcare Corp Senior VP & CIO Ben Anderson Flatt Sr reported a compensation-related stock option exercise. He exercised options for 3,734 shares of common stock at an exercise price of $53.94 per share, originally granted under the 2020 Omnibus Equity Incentive Plan.
To cover the exercise price and related tax withholding obligations, the company withheld 1,909 shares of common stock valued at $176.81 per share, a non-market disposition. Following these transactions, he directly beneficially owns 21,375.0547 shares of National Healthcare common stock.
He also continues to hold stock options over additional common shares, including 8,000 underlying shares at an exercise price of $94.10 expiring in 2029, 9,000 underlying shares at $90.62 expiring in 2030, and 14,000 underlying shares at $157.13 expiring in 2031.
National HealthCare Corporation is asking shareholders to vote at its 2026 annual meeting on May 7, 2026 in Murfreesboro, Tennessee. Items include re‑electing directors Emil E. Hassan, Lisa Piercey, M.D., and William A. “Andrew” Adams and an advisory vote on executive pay.
For 2025, pre‑tax earnings excluding unrealized securities gains were $137,497,000, creating an executive bonus pool of $6,874,841, split 80% cash and 20% restricted stock. CEO Stephen F. Flatt’s 2025 pay totaled $2,685,370, including a $577,000 salary and $1,280,000 bonus. The company highlights board independence, refreshed membership, sustainability efforts, and updated insider trading, clawback, and cybersecurity oversight policies.
National HealthCare Corp Schedule 13G/A: The Vanguard Group amended its beneficial ownership filing following an internal realignment. The amendment states amount beneficially owned: 0 shares and percent of class: 0%. The filing explains certain subsidiaries/divisions now report separately in reliance on SEC Release No. 34-39538 (January 12, 1998), and Vanguard no longer is deemed to beneficially own the securities held by those units. The filing is signed by a Vanguard officer on 03/27/2026.